TELA Bio Inc
TELA1.900USD
+0.040+2.15%
交易中 （美東）報價延遲15分鐘
75.15M總市值
虧損本益比TTM
關於 TELA Bio Inc 公司
TELA Bio, Inc. 是一家商業階段的醫療技術公司。該公司專注於提供軟組織重建解決方案，通過優先保護和恢復患者自身的解剖結構來優化臨牀結果。其首批產品組合 OviTex 增強組織基質 (OviTex) 解決了疝氣修復和腹壁重建方面尚未滿足的需求。其 OviTex 產品組合包括多種產品配置，旨在解決疝氣修復和腹壁重建中的各種外科手術，包括腹股溝疝、腹股溝疝和食管裂孔疝修復。該公司的 OviTex 產品包括 OviTex 1S、OviTex 2S 和 OviTex LPR。其第二批產品組合 OviTex PRS 增強組織基質 (OviTex PRS) 解決了整形和重建外科方面尚未滿足的需求。OviTex PRS 適用於植入，以加強需要軟組織修復的患者中存在的軟組織薄弱處。
公司簡介
公司代碼TELA
公司名稱TELA Bio Inc
上市日期Nov 08, 2019
CEOMr. Antony Koblish
員工數量209
證券類型Ordinary Share
年結日Nov 08
公司地址1 Great Valley Parkway, Suite 24
城市MALVERN
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編19355
電話14843202930
網址https://www.telabio.com/
公司代碼TELA
上市日期Nov 08, 2019
CEOMr. Antony Koblish
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Ms. Lisa N. Colleran
Ms. Lisa N. Colleran
Independent Director
Independent Director
14.22K
+126.79%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Ms. Lisa N. Colleran
Ms. Lisa N. Colleran
Independent Director
Independent Director
14.22K
+126.79%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
業務USD
名稱
營收
佔比
OviTex
12.11M
65.38%
OviTex PRS
6.04M
32.63%
Other
367.00K
1.98%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
OviTex
12.11M
65.38%
OviTex PRS
6.04M
32.63%
Other
367.00K
1.98%
股東統計
更新時間: 7月31日 週四
更新時間: 7月31日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
12.92%
EW Healthcare Partners
10.39%
North Run Capital, LP
9.31%
SilverArc Capital Management, LLC
7.01%
Lytton (Laurence W)
6.20%
Other
54.17%
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
12.92%
EW Healthcare Partners
10.39%
North Run Capital, LP
9.31%
SilverArc Capital Management, LLC
7.01%
Lytton (Laurence W)
6.20%
Other
54.17%
股東類型
持股股東
佔比
Hedge Fund
41.50%
Investment Advisor
11.37%
Venture Capital
10.42%
Investment Advisor/Hedge Fund
10.10%
Individual Investor
8.40%
Research Firm
2.33%
Other
15.89%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
184
33.43M
84.52%
-6.77M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
2023Q2
142
22.34M
91.32%
+1.25M
2023Q1
130
16.96M
88.34%
-4.55M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Nantahala Capital Management, LLC
5.11M
12.92%
+1.23M
+31.81%
Apr 30, 2025
EW Healthcare Partners
4.11M
10.39%
--
--
Mar 31, 2025
North Run Capital, LP
3.68M
9.31%
+1.70M
+85.75%
Mar 31, 2025
SilverArc Capital Management, LLC
2.77M
7.01%
-294.36K
-9.60%
Mar 31, 2025
Lytton (Laurence W)
2.45M
6.2%
+1.11M
+83.00%
Sep 30, 2024
Stonepine Capital Management, LLC
2.06M
5.2%
-297.87K
-12.66%
Mar 31, 2025
The Vanguard Group, Inc.
1.93M
4.87%
+52.59K
+2.80%
Mar 31, 2025
Dafna Capital Management, LLC
1.44M
3.64%
--
--
Mar 31, 2025
Grow Funds LLC
1.40M
3.54%
+1.40M
--
Jul 24, 2024
Pentwater Capital Management LP
998.75K
2.52%
-1.25K
-0.12%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Proshares Ultra Russell 2000
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
